Description
FORMA FARMACÉUTICA: 2 JERINGA PRELLENADA
un inhibidor de la aromatasa utilizado para el tratamiento de cáncer de mama en mujeres posmenopáusicas
DOSIS: 800 G
Principio activo: Salbutamol
DOSIS: 100/37
SOL GLUCO DX 5% PISA 250ML VITAMINAB1YB6 FORMA FARMACÉUTICA: 2 JERINGA PRELLENADAPRINCIPIO ACTIVO: ELECTROLITOS PARENTERALES 0. 05 DOSIS: 250 ML FORMA FARMACUTICA: 1 SOLUCION GLUCOSADA PRESENTACIN: 1 FRASCO
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
